TGF-β1 Blockade Restores Bone Marrow Endothelial Function
A study reveals that TGF-β1 drives maladaptive bone marrow endothelial cell repair, impairing haematopoietic support. Blocking TGF-β1 with luspatercept restored cell function and improved blood cell recovery in post-transplant patients.